prednisolone has been researched along with Mast-Cell Leukemia in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sipos, W | 1 |
| Hirschberger, J | 1 |
| Breuer, W | 1 |
| Zenker, I | 1 |
| Elicker, S | 1 |
| Hauswirth, AW | 1 |
| Simonitsch-Klupp, I | 1 |
| Uffmann, M | 1 |
| Koller, E | 1 |
| Sperr, WR | 1 |
| Lechner, K | 1 |
| Valent, P | 1 |
1 review available for prednisolone and Mast-Cell Leukemia
| Article | Year |
|---|---|
Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.
Topics: Adult; Bone Marrow; Disease Progression; Drug Evaluation; Drug Therapy, Combination; Female; Fever; | 2004 |
1 other study available for prednisolone and Mast-Cell Leukemia
| Article | Year |
|---|---|
Partial remission of mast cell leukaemia in a minipig after chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Drug | 2010 |